Compare Payoneer Global Inc (PAYO) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Payoneer Global Inc vs Twist Bioscience Corp — how do they compare? Payoneer Global Inc trades at $7.13 (market cap $2.41B), while Twist Bioscience Corp trades at $95.03 (market cap $5.97B). The key difference: Twist Bioscience Corp is far larger — about 2.5× Payoneer Global Inc's market cap. Which is the better fit depends on your goals.
| PAYO | TWST | |
|---|---|---|
Market Cap | $2.41B | $5.97B |
Sector | Technology | Health |
52-Week High | $7.42 | $102.88 |
52-Week Low | $4.27 | $24.16 |
Enterprise Value | $2.15B | $5.89B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Payoneer Global (PAYO) trades at $7.12, unchanged on the day, with a bullish technical signal driven by moving averages. The company reported Q1 2026 EPS of $0.06, beating expectations, but faces scrutiny over its proposed acquisition by Nuvei for $7.40 per share. Revenue grew to $821 million in 2025, though net income fell to $73 million. Analyst consensus is 60% buy with a $8.20 price target, suggesting moderate upside from current levels.
The outlook is mixed: the acquisition offers a near-term floor but may undervalue growth potential. Risks include integration challenges and earnings volatility. Upside depends on execution of expansion initiatives like the new India tech hub. Investors should weigh acquisition certainty against long-term standalone value.
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
